Ostrum Asset Management’s AbbVie ABBV Stock Holding History

Ostrum Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.52M	Buy	29,986 +5,725	+24%	+$1.27M	0.37%	39
2025 Q4	$5.54M	Sell	24,261 -1,499	-6%	-$341K	0.27%	51
2025 Q3	$5.96M	Sell	25,760 -5,594	-18%	-$1.14M	0.27%	56
2025 Q2	$5.82M	Sell	31,354 -2,591	-8%	-$482K	0.27%	62
2025 Q1	$7.11M	Buy	33,945 +2,738	+9%	+$532K	0.37%	41
2024 Q4	$5.55M	Sell	31,207 -564	-2%	-$104K	0.48%	32
2024 Q3	$6.27M	Buy	31,771 +561	+2%	+$105K	0.52%	32
2024 Q2	$5.35M	Sell	31,210 -8,650	-22%	-$1.43M	0.47%	35
2024 Q1	$7.26M	Sell	39,860 -3,970	-9%	-$684K	0.57%	21
2023 Q4	$6.79M	Buy	43,830 +19,028	+77%	+$2.77M	0.59%	23
2023 Q3	$3.7M	Sell	24,802 -1,943	-7%	-$285K	0.34%	67
2023 Q2	$3.6M	Sell	26,745 -287	-1%	-$42.1K	0.3%	96
2023 Q1	$4.31M	Buy	+27,032	New	+$4.13M	0.38%	67

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ostrum Asset Management's ABBV Position: Q1 2026 in Review

Ostrum Asset Management increased its AbbVie (ABBV) stake by 24% in Q1 2026, buying an estimated $1.27M and bringing the position to 29,986 shares worth $6.52M. The position accounts for 0.37% of the portfolio, ranked #39.

Ostrum Asset Management first reported a position in ABBV in Q1 2023 and has held it in 13 quarters since. The position peaked at $7.26M in Q1 2024. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Ostrum Asset Management held 29,986 shares of AbbVie worth $6.52M as of Q1 2026.
Ostrum Asset Management bought 5,725 AbbVie shares in Q1 2026, an estimated $1.27M.
AbbVie made up 0.37% of Ostrum Asset Management's portfolio in Q1 2026, its #39 holding.
Ostrum Asset Management first reported a position in AbbVie in Q1 2023 and has held it in 13 quarters since.
Ostrum Asset Management's AbbVie position peaked at $7.26M in Q1 2024.
4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Ostrum Asset Management's 13F filing for Q1 2026, filed 14 May 2026.